CUSIP: 12648L106
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
81,343,382
-
Share change
-
-28,263,588
-
Total reported value
-
$27,654,068
-
Price per share
-
$0.34
-
Number of holders
-
55
-
Value change
-
-$11,198,578
-
Number of buys
-
24
-
Number of sells
-
51
Quarterly Holders Quick Answers
What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2016
-
Previous quarter:
Q1 2016
Recent filing periods for CUSIP 12648L106:
Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q2 2016
As of 30 Jun 2016,
CTI BIOPHARMA CORP - COM (CTIC) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,343,382 shares.
The largest 10 holders included
BVF INC/IL, FMR LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, JACOBS LEVY EQUITY MANAGEMENT, INC, GEODE CAPITAL MANAGEMENT, LLC, Paloma Partners Management Co, and Alyeska Investment Group, L.P..
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.